NO883073D0 - 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter. - Google Patents

3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.

Info

Publication number
NO883073D0
NO883073D0 NO883073A NO883073A NO883073D0 NO 883073 D0 NO883073 D0 NO 883073D0 NO 883073 A NO883073 A NO 883073A NO 883073 A NO883073 A NO 883073A NO 883073 D0 NO883073 D0 NO 883073D0
Authority
NO
Norway
Prior art keywords
acid derivatives
desmethyl
procedure
preparation
intermediate products
Prior art date
Application number
NO883073A
Other languages
English (en)
Other versions
NO170803C (no
NO883073L (no
NO170803B (no
Inventor
Kurt Kesseler
Gerhard Beck
Wilhelm Bartmann
Ernold Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883073D0 publication Critical patent/NO883073D0/no
Publication of NO883073L publication Critical patent/NO883073L/no
Publication of NO170803B publication Critical patent/NO170803B/no
Publication of NO170803C publication Critical patent/NO170803C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
NO883073A 1987-07-10 1988-07-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater samt forbindelser til bruk ved fremgangsmaaten NO170803C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3722808 1987-07-10

Publications (4)

Publication Number Publication Date
NO883073D0 true NO883073D0 (no) 1988-07-08
NO883073L NO883073L (no) 1989-01-11
NO170803B NO170803B (no) 1992-08-31
NO170803C NO170803C (no) 1992-12-09

Family

ID=6331293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883073A NO170803C (no) 1987-07-10 1988-07-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater samt forbindelser til bruk ved fremgangsmaaten

Country Status (20)

Country Link
US (1) US4925852A (no)
EP (1) EP0307342B1 (no)
JP (1) JPH0641448B2 (no)
KR (1) KR960009434B1 (no)
AT (1) ATE132496T1 (no)
AU (1) AU609149B2 (no)
CA (1) CA1314873C (no)
CY (1) CY2024A (no)
DE (1) DE3854854D1 (no)
DK (1) DK175231B1 (no)
ES (1) ES2082755T3 (no)
FI (1) FI90236C (no)
GR (1) GR3018825T3 (no)
HU (2) HU206111B (no)
IE (1) IE71031B1 (no)
IL (1) IL87034A (no)
NO (1) NO170803C (no)
NZ (1) NZ225344A (no)
PT (1) PT87929B (no)
ZA (1) ZA884919B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3722809A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
EP0308736A3 (en) * 1987-09-12 1990-02-14 Nissan Chemical Industries Ltd. Pyrimidine type mevalonolactones
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
DE3826814A1 (de) * 1988-08-06 1990-02-08 Hoechst Ag Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NZ230121A (en) * 1988-08-29 1993-08-26 Squibb & Sons Inc Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
FR2649699A1 (fr) * 1989-07-13 1991-01-18 Rhone Poulenc Agrochimie 4-phenyl pyrimidine fongicides
IL91418A (en) * 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
DE3925636A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Imino-substituierte pyridine
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
US5288928A (en) * 1990-12-21 1994-02-22 Ciba-Geigy Corporation Asymmetrical hydrogenation
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US5202327A (en) * 1991-07-10 1993-04-13 E. R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors
DE4243279A1 (de) * 1992-12-21 1994-06-23 Bayer Ag Substituierte Triole
DE4244029A1 (de) * 1992-12-24 1994-06-30 Bayer Ag Neue substituierte Pyridine
DE19610932A1 (de) * 1996-03-20 1997-09-25 Bayer Ag 2-Aryl-substituierte Pyridine
DE19627420A1 (de) * 1996-07-08 1998-01-15 Bayer Ag 6-(Hydroxymethyl-ethyl)pyridine
WO1999041237A1 (en) 1998-02-13 1999-08-19 G.D. Searle & Co. Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
US6383954B1 (en) 1999-07-27 2002-05-07 Applied Materials, Inc. Process gas distribution for forming stable fluorine-doped silicate glass and other films
US6620821B2 (en) 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US6812345B2 (en) 2000-06-15 2004-11-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US6627636B2 (en) 2000-06-15 2003-09-30 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
CN101080232A (zh) * 2004-12-15 2007-11-28 索尔瓦药物有限公司 包含NEP－抑制剂、内源性内皮素产生系统的抑制剂和HMG CoA还原酶抑制剂的药物组合物
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US7659281B2 (en) 2006-04-25 2010-02-09 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors
ME01901B (me) 2006-07-05 2014-12-20 Astrazeneca Ab Kombinacija inhibitora HMG-CoA reduktaze atorvastatina ili simvastatina sa fosfodiesteraza 4 inhibitorom, kao što je roflumilast za lečenje inflamatornih pulmonarnih oboljenja
GB0904104D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Atorvastatin and rosuvastatin derivatives
GB0904100D0 (en) 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of rosuvastatin lactols as medicaments
KR101174246B1 (ko) 2011-12-12 2012-08-14 이종걸 진자 운동과 회전운동을 병행하는 램프를 갖는 휴대가능한 전기 양초
US20140370060A1 (en) 2012-02-02 2014-12-18 The University Of Sydney Tear Film Stability
KR102201274B1 (ko) * 2015-09-09 2021-01-12 현대자동차주식회사 차량의 서스펜션 제어방법
MX2019009213A (es) 2017-01-23 2019-09-27 Dong Wha Pharm Co Ltd Formulación compleja que comprende inhibidor de la hmg-coa reductasa y clopidogrel.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
EP0308736A3 (en) * 1987-09-12 1990-02-14 Nissan Chemical Industries Ltd. Pyrimidine type mevalonolactones
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
NO890521L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte pyrimidiner.

Also Published As

Publication number Publication date
NZ225344A (en) 1990-08-28
NO170803C (no) 1992-12-09
HU206111B (en) 1992-08-28
IE882099L (en) 1989-01-10
EP0307342A3 (en) 1990-02-07
FI883249A (fi) 1989-01-11
DK383688A (da) 1989-01-11
ZA884919B (en) 1989-01-18
AU609149B2 (en) 1991-04-26
NO883073L (no) 1989-01-11
IL87034A (en) 1993-02-21
DK175231B1 (da) 2004-07-19
JPH0641448B2 (ja) 1994-06-01
DK383688D0 (da) 1988-07-08
AU1888288A (en) 1989-01-12
KR960009434B1 (ko) 1996-07-19
IE71031B1 (en) 1997-01-15
FI90236C (fi) 1994-01-10
CA1314873C (en) 1993-03-23
PT87929B (pt) 1995-03-01
CY2024A (en) 1998-02-20
PT87929A (pt) 1989-06-30
HU210722A9 (en) 1995-06-28
FI90236B (fi) 1993-09-30
ATE132496T1 (de) 1996-01-15
FI883249A0 (fi) 1988-07-07
EP0307342A2 (de) 1989-03-15
HUT54144A (en) 1991-01-28
DE3854854D1 (de) 1996-02-15
JPS6429362A (en) 1989-01-31
IL87034A0 (en) 1988-12-30
KR890002119A (ko) 1989-04-08
NO170803B (no) 1992-08-31
GR3018825T3 (en) 1996-04-30
EP0307342B1 (de) 1996-01-03
ES2082755T3 (es) 1996-04-01
US4925852A (en) 1990-05-15

Similar Documents

Publication Publication Date Title
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
DK0418648T3 (da) 4-Hydroxytetrahydropyran-2-oner samt de tilsvarende dihydroxycarboxylsyrederivater, salte og estere, fremgangsmåde til deres fremstilling, farmaceutiske præparater samt precursorer
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
DK383388A (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
DK119188D0 (da) Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne
DK114286D0 (da) Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
DK222588D0 (da) 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
MK1K Patent expired